AESTHETIC NEWSAESTHETIC NEWS

The acquisition enhances patient care and extends CLS Health’s geographical reach in the Houston area.

Southeast Houston Cardiology & CLS Health
CLS Health completes acquisition of Southeast Houston Cardiology

HOUSTON, September 13, 2023 (Newswire.com)
–
CLS Health, formerly known as Clear Lake Specialties, has finalized the acquisition of Southeast Houston Cardiology, a leading cardiology practice. This move is part of CLS Health’s strategic expansion in the Houston metropolitan area and comes shortly after its recent merger with Clear Lake Cardiovascular Consultants. 

Strategic Alignment and Patient Care 

“The acquisition of Southeast Houston Cardiology allows us to offer specialized cardiac care to our growing patient base of over 80,000. It aligns perfectly with our strategic priorities of geographical expansion and providing comprehensive healthcare,” says Dr. Mohammad Baba, President of CLS Health. “In a market that is being invaded by outside venture capitalists and insurance companies, CLS Health allows our community’s doctors to preserve their independence and their ability to provide excellent healthcare.” 

“Partnering with CLS Health allows us to better serve the Houston community. It’s a positive step for both practices,” says Dr. David Hamer, Founder of Southeast Houston Cardiology.

Operational Excellence and Community Impact 

Immediate plans include utilizing CLS Health’s resources to improve operations, offer more in-house ancillary services, and connect patients to a larger network. “Both CLS Health and Southeast Houston Cardiology have a long-standing commitment to community healthcare,” said Dr. Dweik, Vice President. “With this acquisition, we’re putting specialized, compassionate cardiac care within easy reach of those who live and work in these rapidly growing communities.” 

Future Outlook and New Facilities 

This acquisition comes on the heels of CLS Health’s newest 100,000-square-foot planned addition to its main campus at 600 North Kobayashi Road, Webster, which will include a cardiac catheterization laboratory and an ambulatory surgery center. “The new facilities at our main campus and this acquisition are synergistic steps to provide comprehensive cardiac care across the Greater Houston area,” added Shahbaz Rabbani, Director of Operations, CLS Health. 

Leadership in Cardiology 

Combined with the prior merger with Clear Lake Cardiovascular Consultants, these strategic moves position CLS Health at the forefront of Houston’s cardiology footprint. “With more than 15 providers, Cardiology has become CLS Health’s second-largest service line, only behind primary care,” noted Shahbaz Rabbani, Director of Operations, CLS Health. 

About CLS Health 

CLS Health, formerly known as Clear Lake Specialties, is a leading multispecialty group practice founded with the mission to provide comprehensive and specialized medical care in the Greater Houston area. Our team comprises over 160+ physicians and allied health professionals who practice across 23 locations, offering medical services in 30+ specialties. For more information, visit cls.health.

Contact Information:

Isaiah Rincon

Media Relations Manager

[email protected]

8328587307

Original Source:

CLS Health Acquires Southeast Houston Cardiology, Expanding Cardiology Services

Pharmacy benefit manager’s new brand pillars leverage strengths to better serve their partners and clients.

Serve You Rx Brand Shift
Pharmacy benefit manager’s new brand pillars leverage strengths to better serve their partners and clients.

MILWAUKEE, September 13, 2023 (Newswire.com)
–
Serve You Rx, a pharmacy benefit management (PBM) company focused on service and flexibility, unveiled its new branding today. Flexibility, quality, and a client-centered approach are central to its transformation. These brand pillars reflect the company’s evolved approach to the market and underscore a paradigm shift in thinking. 

The PBM industry is undergoing significant transformations, driven by the rising complexity and cost of prescription drugs, decreased satisfaction with PBM providers, and an increased focus on transparency. With its dedication to quality, adaptability, and client-centricity, Serve You Rx is poised to deliver innovative solutions that address these challenges. 

Ted Boylan, PharmD, President of Serve You Rx, believes the rebranding project supports the new phase of growth and innovation the company is experiencing. “Guided by the pillars of flexibility, quality, and client-centricity, we are developing and delivering what our customers demand — impactful programs and partnerships that exceed cost management and service expectations,” Boylan said.

For 36 years, Serve You Rx has built a successful business serving small- and mid-market self-insured groups. Today, with clients nationwide, Serve You Rx serves a diverse range of organizations, including commercial employers, government entities, labor unions, tribal nations, hospitals and health systems, coalitions, and captives. 

“In a time when the PBM sector is grappling with dissatisfaction and calls for greater transparency, Serve You Rx is stepping up to redefine what a PBM partner focused on you can do,” said Serve You Rx CEO Justin Jasniewski. “This rebrand isn’t a mere aesthetic change; it’s our renewed vow to deliver unparalleled service and value to our clients.”

For more information about the company and its services, visit ServeYouRx.com. 

About Serve You Rx  
Serve You Rx is a full-service pharmacy benefit manager (PBM) with unquestionable flexibility and an unwavering commitment to doing what’s best for its clients. With a fervent focus on those it serves, including insurance brokers, consultants, third-party administrators, and their clients, Serve You Rx delivers exceptional service and tailored, cost-effective benefit solutions. Independent and privately held for over 36 years, Serve You Rx can implement new groups in 30 days or less and say “yes” to a wide variety of viable solutions. Known for its adaptability, quality, and client-centricity, Serve You Rx aims to be a benchmark for better client service.

Contact Information:

Nancy Fleming

Marketing Director

[email protected]

414-410-8164

Original Source:

Serve You Rx Transforms Pharmacy Benefit Management With New Client-Centered Branding Strategy

ANN ARBOR, Mich., September 13, 2023 (Newswire.com)
–
LanguageLine Solutions, the world leader in language access and interpretation services, has annou…

Leveraging Product Security Hub’s platform, Apraciti Announces the Launch of the 2nd Annual Medical Device Cybersecurity Industry Benchmarking Assessment and Encourages all Medical Device Manufacturers to Participate

HADDONFIELD, N.J., September 12, 2023 (Newswire.com)
–
Apraciti, LLC, a leading provider of medical device cybersecurity services, has today announced the launch of the 2^nd Annual Medical Device Cybersecurity Industry Benchmarking Assessment in Partnership with the Medical Device Innovation Consortium. The complimentary assessment is hosted by Product Security Hub, a platform and workplace for medical device cybersecurity, built for medical device manufacturers. 

“One of the goals we had in developing the original Joint Security Plan (“JSP”) with the Healthcare and Public Health Sector Coordinating Council was to provide medical device manufacturers with information and tools to help them build and mature their product security programs to further protect patient safety. With the release of the 2^nd Annual Assessment, we are continuing to support that mission and help drive the industry forward in such a critical domain,” said Colin Morgan, Managing Director of Apraciti, LLC.   

Companies who take part in the survey will gain an understanding of their overall maturity rating, based on the JSP, as well as security domain ratings and details of how each question was answered. This will provide them the opportunity to assess their current position and determine areas for improvement.

“It’s common for Product Security leaders to be asked how their program compares to their peers in the industry, or what aspects of the program should be prioritized to continuously improve. Participating in this assessment is a great starting point to help begin to answer these important questions,” said Morgan.

The assessment can be found by navigating to the Product Security Hub Login Instructions page (https://productsecurityhub.com/product-security-hub-login-instructions/).

About Apraciti, LLC

Apraciti, LLC specializes in providing comprehensive cybersecurity services tailored specifically for medical device manufacturers. With a dedicated focus on product security, Apraciti offers services and expertise to help fortify the security of products and programs. Apraciti’s mission is to ensure the cybersafety, reliability, and compliance of medical devices, thereby safeguarding patient safety and building trust in the healthcare industry. Please visit us at https://www.apraciti.com or follow on LinkedIn https://www.linkedin.com/company/apraciti.

About Product Security Hub, LLC

Product Security Hub offers multiple solutions for medical device manufacturers to help manage cybersecurity across their program and products, such as ProdSecMaturity and ProdSecDesigner. With ProdSecMaturity, companies can assess the maturity of their company operations and processes, identify and plan goals, prioritize activities, and mature their cybersecurity program. Companies can also assess their organization’s maturity on industry frameworks such as the FDA Pre-Market Cybersecurity Draft Guidance, FDA Post-Market Management of Cybersecurity in Medical Devices, EU MDCG Cybersecurity for Devices Regulatory Requirements and more. ProdSecDesigner enables design and development teams to inventory products, document components, analyze threats, manage requirements, and review residual risks.  For more information, please visit https://www.productsecurityhub.com or follow on LinkedIn https://www.linkedin.com/company/productsecurityhub. 

Contact Information:

Colin Morgan

Managing Director

[email protected]

215-613-9900

Original Source:

Apraciti Announces the Launch of the 2nd Annual Medical Device Cybersecurity Industry Benchmarking Assessment in Partnership With the Medical Device Innovation Consortium

Coronary Heart Disease (CHD) prevention nearly twice as effective when using CARDIO inCode
as method to target treatment

…